1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 1-(4-Chlorobenzyl)-3-[(4-benzoylbutyryl)amino]homopiperidine

HRID 133629

Reaktionsgleichung

Reaktionsgleichung von HRID 133629
CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.[NH2:22][CH:23]1[CH2:29][CH2:28][CH2:27][CH2:26][N:25]([CH2:30][C:31]2[CH:36]=[CH:35][C:34]([Cl:37])=[CH:33][CH:32]=2)[CH2:24]1.[C:38]([CH2:46][CH2:47][CH2:48][C:49](O)=[O:50])(=[O:45])[C:39]1[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=1>ClCCl.C(Cl)(Cl)Cl.C(N(CC)CC)C>[Cl:37][C:34]1[CH:33]=[CH:32][C:31]([CH2:30][N:25]2[CH2:26][CH2:27][CH2:28][CH2:29][CH:23]([NH:22][C:49](=[O:50])[CH2:48][CH2:47][CH2:46][C:38](=[O:45])[C:39]3[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=3)[CH2:24]2)=[CH:36][CH:35]=1

Komponenten

8

Reaktionsbedingungen

Temperatur
25 °C

Versuchsvorschrift

EDCI (23 mg), HOBt (16.2 mg) and triethylamine (15.2 μL) were added to a chloroform (1 mL) solution of 3-amino-1-(4-chlorobenzyl)homopiperidine (24 mg, 0.10 mmol) and 4-benzoylbutyric acid (1.2 equivalents), and the resulting mixture was stirred at 25° C. for 16 hours. The reaction mixture was diluted with dichloromethane (0.5 mL), filtered through a PTFE membrane and concentrated to provide 1-(4-chlorobenzyl)-3-[(4-benzoylbutyryl)amino]homopiperidine (Compd. No. 994) (43 mg, 99%). The purity was determined by RPLC/MS (98%). ESI/MS m/e 413 (M++H, C24H29ClN2O2).

Aufarbeitung

  1. filtrationfiltered through a PTFE membrane
  2. concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag
ord-dba731bce0ea47c6ab606634cae1e2a4
Quelldatensatz
uspto-grants-2008_06
Patentnummer
US07390830B1

Verknüpfte Notizen

Wird geladen…